iifl-logo-icon 1

Eiko Lifesciences Ltd Share Price

57
(0.32%)
Sep 18, 2024|09:49:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open57
  • Day's High57
  • 52 Wk High81.32
  • Prev. Close56.82
  • Day's Low57
  • 52 Wk Low 45.1
  • Turnover (lac)0.05
  • P/E69.29
  • Face Value10
  • Book Value40.36
  • EPS0.82
  • Mkt. Cap (Cr.)70.96
  • Div. Yield0
View All Historical Data
No Records Found

Eiko Lifesciences Ltd KEY RATIOS

Sector

Chemicals

Open

57

Prev. Close

56.82

Turnover(Lac.)

0.05

Day's High

57

Day's Low

57

52 Week's High

81.32

52 Week's Low

45.1

Book Value

40.36

Face Value

10

Mkt Cap (₹ Cr.)

70.96

P/E

69.29

EPS

0.82

Divi. Yield

0

Eiko Lifesciences Ltd Corporate Action

30 Jun 2023

12:00 AM

Rights

arrow

5 Aug 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

30 Aug 2023

12:00 AM

AGM

Announcement Date: 30 Aug, 2023

arrow

Eiko Lifesciences Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Eiko Lifesciences Ltd SHAREHOLDING SNAPSHOT

18 Sep, 2024|10:10 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 24.40%

Foreign: 0.00%

Indian: 24.40%

Non-Promoter- 75.59%

Institutions: 0.00%

Non-Institutions: 75.59%

Custodian: 0.00%

Share Price

Eiko Lifesciences Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

12.87

8.32

8.32

10.16

Preference Capital

0

0

0

0

Reserves

37.81

21.11

20.31

2.37

Net Worth

50.68

29.43

28.63

12.53

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2016Mar-2015

Revenue

25.41

11.99

0

0

yoy growth (%)

111.93

0

0

0

Raw materials

-22.58

-10.61

0

0

As % of sales

88.86

88.5

0

0

Employee costs

-0.27

-0.11

0

0

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2016Mar-2015

Profit before tax

0.94

0.83

0

0

Depreciation

-0.56

-0.06

0

0

Tax paid

-0.23

-0.21

0

0

Working capital

2.57

7.66

0.67

0.07

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2022Mar-2021Mar-2016Mar-2015

Growth matrix (%)

Revenue growth

111.93

0

0

0

Op profit growth

148.21

0

0

0

EBIT growth

52.76

0

0

0

Net profit growth

14.87

0

0

0

View Ratios
Particulars (Rupees in Crores.)Mar-2020Mar-2019Mar-2018

Gross Sales

10.35

4.25

2.34

Excise Duty

0

0

0

Net Sales

10.35

4.25

2.34

Other Operating Income

0

0

0

Other Income

0.06

0.06

0.06

Eiko Lifesciences Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Pidilite Industries Ltd

PIDILITIND

3,269.9

88.541,66,311.53551.570.493,145.84163.92

SRF Ltd

SRF

2,430.35

57.2472,041.61249.940.32,676.63353.96

Linde India Ltd

LINDEINDIA

8,082.75

156.7668,929.69111.540.15653.23402.73

Gujarat Fluorochemicals Ltd

FLUOROCHEM

4,395.2

153.2548,281.271110.071,085539.16

Godrej Industries Ltd

GODREJIND

1,228.35

041,364.74105.260986.4545.02

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Eiko Lifesciences Ltd

Management

Register Office

Registrar Office

Chairman & Non Executive Dir.

Laxmikant Kabra

Non-Exec & Non-Independent Dir

Bhavesh Dhirajlal Tanna

Independent Non Exe. Director

Rajkumar K Baheti

Independent Non Exe. Director

Mandkar Kamalakar Patil

Independent Non Exe. Director

Kajal Dhanpatraj Kothari

Whole-time Director

Umesh Ravindranath More

Company Sec. & Compli. Officer

Chintan Doshi

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Eiko Lifesciences Limited was originally incorporated on January 07, 1977, under the name Narendra Investments (Delhi) Limited. Later, the Company changed its name from Narendra Investments (Delhi) Limited to Eiko LifeSciences Limited effective from June 24, 2021. Earlier, the Company engaged in sale and purchase of shares and securities. At present, the Company is a leading manufacturer, supplier and exporter of Speciality Chemicals and Pharma Intermediates in India and globally. The Company commenced new business activity primarily in manufacturing of speciality and fine chemicals in October, 2020 from manufacturing facility located at Badlapur, Maharashtra and has since scaled its operations, grown brand and customer base to become the one of the fastest growing speciality chemicals companies in India. The key products manufactured by Company are used in pharmaceutical and agrochemical industries with various end use application including corrosion control, photographic chemicals, solvents, and corrosion inhibitors amongst others.In 2022, it completed the development of new molecules for Agrochemical Intermediates, Polymer Science and Pharma segment. Eiko developed these molecules and launched the same during the second quarter of FY 2022. The Company has ventured in the business of manufacturing, processing, formulating, producing, buying, selling, and exporting Speciality and Fine Chemicals in year 2023. These products find application in a host of Agrochemical, Personal
Read More

Company FAQs

What is the Eiko Lifesciences Ltd share price today?

Down Arrow

The Eiko Lifesciences Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹57 today.

What is the Market Cap of Eiko Lifesciences Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Eiko Lifesciences Ltd is ₹70.96 Cr. as of 18 Sep ‘24

What is the PE and PB ratio of Eiko Lifesciences Ltd?

Down Arrow

The PE and PB ratios of Eiko Lifesciences Ltd is 69.29 and 1.41 as of 18 Sep ‘24

What is the 52 Week High and Low of Eiko Lifesciences Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Eiko Lifesciences Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Eiko Lifesciences Ltd is ₹45.1 and ₹81.32 as of 18 Sep ‘24

What is the CAGR of Eiko Lifesciences Ltd?

Down Arrow

Eiko Lifesciences Ltd's CAGR for 5 Years at 14.13%, 3 Years at -13.23%, 1 Year at -7.20%, 6 Month at -1.92%, 3 Month at 14.05% and 1 Month at -6.36%.

What is the shareholding pattern of Eiko Lifesciences Ltd?

Down Arrow

The shareholding pattern of Eiko Lifesciences Ltd is as follows:
Promoters - 24.40 %
Institutions - 0.00 %
Public - 75.60 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020
  • Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.
  • Pay 20% upfront margin of the transaction value to trade in cash market segment.
  • Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.
  • Check your Securities / MF / Bonds in the consolidated account statement issued by NSDL/CDSL every month.
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp